Skip to content

Twentyfour Ambulatory Pulse Wave Velocity and Central Augmentation Index in Type 2 Diabetes

Twentyfour Ambulatory Pulse Wave Velocity and Central Augmentation Index in Type 2 Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01812811
Enrollment
22
Registered
2013-03-18
Start date
2012-09-30
Completion date
2013-07-31
Last updated
2013-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

pulse wave analysis, pulse wave velocity, Arteriograph24, Ambulatory, diabetes, reproducibility, diurnal variation

Brief summary

The functionality and reproducibility of pulse wave analysis is investigated in 20 type 2 diabetic patients who had two 24 hour measurements performed within one week with the Arteriograph24 equipment.

Detailed description

Arteriograph24 is a new monitor for measuring ambulatory blood pressure and additional performing brachial cuff based on analysis of a suprasystolic pulse wave. The study aim to test the feasibility of ambulatory pulse wave analysis every twenty minute (the fraction of missed measurements)and the reprodicility of pulse wave velocity and central augmentation index in type 2 diabetic patients. In addition we will explore the relation between diurnal variation of brachial blood pressure, central blood pressure and pulse wave velocity. 20 type 2 diabetic patients will have 24h ambulatory blood pressure performed twice with an interval of one week.

Interventions

None listed

Sponsors

Regionshospitalet Silkeborg
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Type 2 diabetes

Exclusion criteria

* Atrial fibrillation

Design outcomes

Primary

MeasureTime frameDescription
Fraction of missed pulse wave analysisMeaured two times with an interval of one weekMeasurements of ambulatory blood pressure and pulse wave analysis is performed every twenty minute. The fraction of missed measurements of pulse wave analysis during day time and night time analysis is the final outcome

Secondary

MeasureTime frameDescription
Reproducibility of pulse wave analysis parametersMeasured two times with an interval of one weekReproducibility of pulse wave velocity, Central systolic blood pressure and central augmentation index for 24 hour, day and night

Other

MeasureTime frameDescription
Diurnal variation of brachial blood pressure, central blood pressure and pulse wave velocityMeasured two times with an interval of one weekbrachial blood pressure, central blood pressure and pulse wava velocity is measured evrey twenty minutes and averaged for day time and night time. the relative reduction at nioght for the parameters are calculated

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026